Goncalves Joana — SEC insider filings
SEC reporting owner CIK 1756991. 46 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 46 filings on record, filed 2020-10-22 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 72 legs across 38 filings — 155,050 shares, $6,554,416 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 62.
- Largest priced transaction: sale of 3,320 shares @ $112.01 ($371,886) in Oruka Therapeutics, Inc., filed 2026-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Chief Medical Officer | 14 | — | 46 legs · 86,535 sh · $5,773,799 | 51 |
| Cara Therapeutics, Inc. (CARA) | CHIEF MEDICAL OFFICER | 32 | — | 26 legs · 68,515 sh · $780,617 | 11 |
Insider filings — Goncalves Joana
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,600 @ $99.52 · Sale (S): 1,500 @ $100.48 · Sale (S): 1,900 @ $101.53 · Sale (S): 300 @ $102.47 · +4 more | EDGAR |
| 2026-10-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,853 @ $73.89 · Sale (S): 1,847 @ $74.69 · Sale (S): 1,400 @ $75.48 · Sale (S): 700 @ $76.67 · +3 more | EDGAR |
| 2026-09-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,384 @ $91.10 · Sale (S): 3,150 @ $92.03 · Sale (S): 1,366 @ $92.99 · Sale (S): 100 @ $94.22 · +3 more | EDGAR |
| 2026-08-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 900 @ $109.65 · Sale (S): 300 @ $110.52 · Sale (S): 3,320 @ $112.01 · Sale (S): 2,480 @ $112.56 · +2 more | EDGAR |
| 2026-07-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 400 @ $84.36 · Sale (S): 2,497 @ $85.86 · Sale (S): 3,803 @ $86.68 · Sale (S): 300 @ $87.25 · +2 more | EDGAR |
| 2026-06-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 1,636 @ $68.38 · Sale (S): 5,064 @ $69.42 · Sale (S): 300 @ $70.62 · Sale (S): 947 @ $69.69 · +2 more | EDGAR |
| 2026-05-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,800 @ $61.56 · Sale (S): 2,100 @ $62.42 · Sale (S): 100 @ $63.52 · Option exercise (M): 3,500 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-15 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,227 @ $65.73 · Sale (S): 2,273 @ $66.56 · Sale (S): 500 @ $67.38 · Option exercise (M): 3,500 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 2,921 @ $40.11 · Sale (S): 2,902 @ $41.20 · Sale (S): 1,177 @ $41.94 · Sale (S): 641 @ $41.30 · +2 more | EDGAR |
| 2026-02-17 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 6,064 @ $32.30 · Sale (S): 936 @ $32.78 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0 | EDGAR |
| 2026-01-16 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 4,381 @ $31.56 · Sale (S): 2,619 @ $32.24 · Option exercise (M): 3,500 (derivative) @ $0 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Oruka Therapeutics, Inc. (ORKA) | Option exercise (M): 3,500 @ $6.84 · Option exercise (M): 3,500 @ $7.80 · Sale (S): 641 @ $28.53 · Sale (S): 1,787 @ $29.62 · Sale (S): 1,492 @ $30.70 · Sale (S): 3,080 @ $31.58 · +2 more | EDGAR |
| 2025-01-24 | 4 | Oruka Therapeutics, Inc. (ORKA) | Grant/award (A): 162,500 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,753 @ $0.83 | EDGAR |
| 2024-03-04 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 3,293 @ $0.89 | EDGAR |
| 2024-02-12 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 7,770 @ $0.53 | EDGAR |
| 2024-02-05 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 13,500 @ $0 | EDGAR |
| 2023-06-27 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,723 @ $3.51 | EDGAR |
| 2023-04-06 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,481 @ $4.91 | EDGAR |
| 2023-03-07 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 6,221 @ $9.71 | EDGAR |
| 2023-03-03 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 81,000 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,265 @ $10.20 | EDGAR |
| 2023-01-19 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,265 @ $10.81 | EDGAR |
| 2023-01-03 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,265 @ $10.18 | EDGAR |
| 2022-12-23 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,992 @ $11.27 | EDGAR |
| 2022-04-05 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 1,642 @ $11.91 | EDGAR |
| 2022-03-01 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 20,000 @ $0 · Sale (S): 1,972 @ $10.29 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 12,607 @ $0 | EDGAR |
| 2021-11-03 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 1,000 @ $17.15 | EDGAR |
| 2021-10-28 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 1,000 @ $15 | EDGAR |
| 2021-09-01 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,110 @ $14.20 | EDGAR |
| 2021-08-26 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 6,400 @ $0 | EDGAR |
| 2021-04-23 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 3,000 @ $27.63 | EDGAR |
| 2021-04-01 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 16,000 @ $0 · Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2021-03-24 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 3,000 @ $19.65 | EDGAR |
| 2021-03-08 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 10,000 @ $0 · Sale (S): 3,093 @ $17.98 | EDGAR |
| 2021-02-25 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 4,000 @ $0 · Sale (S): 3,372 @ $19.33 | EDGAR |
| 2021-02-24 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,000 @ $19.73 | EDGAR |
| 2021-01-25 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,000 @ $20.12 | EDGAR |
| 2020-12-30 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 1,298 @ $15.30 | EDGAR |
| 2020-12-29 | 4 | Cara Therapeutics, Inc. (CARA) | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2020-12-23 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,000 @ $15 | EDGAR |
| 2020-11-25 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,000 @ $15.31 | EDGAR |
| 2020-11-13 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,000 @ $15 | EDGAR |
| 2020-10-22 | 4 | Cara Therapeutics, Inc. (CARA) | Sale (S): 2,000 @ $15 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1756991 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs